Anne-Sophie Journé

1PUBLICATIONS
3CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 14, 2022
Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis.

Bénédicte Oxombre, Fahima Madouri, Anne-Sophie Journé

Pageof 1

Frequent Collaborators

1 joint publications

David Montaigne

1 joint publications

Patrick Vermersch

1 joint publications

Patricia Melnyk